First peptide agent enters clinical arena.
Brice
J
J
D017277:Drug Approval; D006801:Humans; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging; D015282:Octreotide / Q000032:analysis; D004369:Pentetic Acid / Q000032:analysis; D011877:Radionuclide Imaging; D012680:Sensitivity and Specificity; D014486:United States Food and Drug Administration
D004369:Pentetic Acid; D015282:Octreotide